Tario, Edson D.
HRN: 26-42-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/28/2024
01/04/2025
IVTT
300mg
Q8h
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes